<DOC>
	<DOCNO>NCT00021788</DOCNO>
	<brief_summary>The goal islet cell transplantation patient Type 1 Diabetes Mellitus provide constant normal blood glucose level . This may eliminate need insulin altogether provide significant reduction amount insulin necessary maintain constant normal blood glucose level . This normalization may prevent slow progression diabetic complication . Furthermore , participant may enjoy healthy lifestyle well quality life . If meet initial inclusion criterion trial , must able give informed consent personally . Then need participate extensive screen process involve many standard test collection laboratory sample make sure transplant suitable safe .</brief_summary>
	<brief_title>Islet Cell Transplantation Alone Patients With Type I Diabetes Mellitus : Steroid-free Immunosuppression</brief_title>
	<detailed_description>The trial may/will utilize follow immunosuppressive medication : tacrolimus ( life-long ) , sirolimus ( life-long ) , daclizumab infliximab You maintain low dos possible medication . GROUP ( 1A ) : The first four participant assign Group A . These participant receive islet cell transplant alone two donor . They receive follow immunosuppressive medication : tacrolimus ( lifelong ) , sirolimus ( lifelong ) , daclizumab . They receive immunosuppressive medication infliximab . GROUP ( 1B ) : The second four participant assign group B . These participant receive islet cell transplant alone one donor . They receive follow immunosuppressive medication : tacrolimus ( lifelong ) , sirolimus ( lifelong ) , daclizumab infliximab . Patients group able stop injecting insulin three month transplant may eligible receive second islet cell transplant . Further participant alternate group assignment above-mentioned manner . The participant group receive follow immunosuppressive medication life , tacrolimus sirolimus . All participant require live two hour transplantation center . When islets become available , notified come immediately hospital transplant . At time numerous test laboratory sample perform make sure ready healthy transplant . You islet cell transplant do special radiology procedure room hospital . You local anesthetic area liver right side along sedative minimize discomfort procedure might cause . A small ( thin ) needle insert liver portal vein islet cell inject . All participant need follow Diabetes Research Institute transplant laboratory sampling , test general islet cell transplant care .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Candidates must age 18 65 Candidates must IDDM least 5 year physician care least 6 month prior enrollment trial . Eligible candidate poorly control insulindependent diabetes mellitus ( IDDM ) manifest sign symptom severe enough incapacitating . These symptom include episode hypoglycemic unawareness ( failure recognize blood glucose level &lt; 54 mg/dl ) episodes require assistance others . Candidates may poor diabetes control despite intensive insulin therapy ( HbA1c &gt; 8.0 % ) . Creatinine clearance &gt; 60 ml/min ) Body Mass Index less 26 Women childbearing age must negative pregnancy test agree follow effective contraceptive measure duration trial . Previous concurrent organ transplant Previous concurrent malignancy Untreated proliferative diabetic retinopathy Unstable cardiovascular status , include positive stress echocardiography ( &gt; age 35 ) Active infection , include xray evidence pulmonary infection Peptic ulcer disease , gall stone , portal hypertension Abnormal liver function test Presence panel reactive antibody &gt; 20 % Creatinine clearance &lt; 60 ml/min HbA1c 12 % Serological evidence HIV , HbsAg , HCV Anemia ( hemoglobin &lt; 12.0 ) Any condition circumstance , include psychogenic factor , preclude therapeutic compliance otherwise make unsafe undergo islet cell transplant . PSA &gt; 4 male</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Type I Diabetes Mellitus</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Islet Cell Transplantation</keyword>
	<keyword>PercutaneousTranshepaticPortalVein Catheterization</keyword>
</DOC>